Figure 2.

Mean channel fluorescence for normal controls and patient groups. AIHA, immune hemolytic anemia; HS, hereditary spherocytosis; IDA, iron deficiency anemia; NC, normal control; MA, megaloblastic anemia; MDS, myelodysplastic syndrome

Mean channel fluorescence for normal controls and patient groups. AIHA, immune hemolytic anemia; HS, hereditary spherocytosis; IDA, iron deficiency anemia; NC, normal control; MA, megaloblastic anemia; MDS, myelodysplastic syndrome